Dongqing Kelly Chen NSW State Cancer Conference 2023

Abstracts this author is presenting:

• The clinically active PARP inhibitor Olaparib ameliorates Doxorubicin-induced Cardiotoxicity in both in vitro and In vivo model — Lunch & Poster Viewing (Even Numbers)